Corporatisation of Science Research

  • 0
  • 3129
Font size:
Print

Corporatisation of Science Research

Context:

  • During the inaugural address of the 107th Science Congress in Bengaluru in January 2020, Prime Minister Narendra Modi outlined the government’s approach to scientific research in India. 
  • By articulating it as a guiding principle, he indicated the development of a new policy on knowledge production under his leadership.

 

Corporatisation of Science Research

About Corporatisation of Science Research:

  • It refers to the trend of transforming public scientific research institutions into entities that operate with a business-like approach, focusing on revenue generation and market-driven outcomes.
  • Key Aspects of Corporatisation
  • Business Model Orientation: Research institutions like CSIR are urged to adopt self-financing models. They’re encouraged to generate revenue through:
      • Technology commercialization
      • Partnerships with private industries
      • Research is increasingly market-driven, emphasising:
      • Projects with commercial potential
      • Quick-return initiatives

 

Corporatisation of Science Research

Advantage of Corporatisation of Science Research:

  • Financial Benefits:
      • Increased funding from private sector investment
      • Financial sustainability with reduced reliance on government funding
      • Better resource allocation and optimization.
  • Research Efficiency and Relevance:
      • Streamlined processes through business-like operations
      • Closer alignment with industry needs and market demands
  • Innovation and Competitiveness:
      • Profit-driven incentives for rapid technological advancements
      • Enhanced global competitiveness in research and development

 

Disadvantage of Corporatisation of Science Research:

  • Loss of Public Interest Focus: The corporatisation trend may lead to a focus on research that is profitable rather than innovative or socially beneficial. 
  • Critics argue that this could compromise the quality and integrity of scientific research, as institutions may prioritise projects that align with corporate interests over those that serve the public good.

 

Corporatisation of Science Research

 

  • Ethical Concerns: Corporate influence in research raises questions about objectivity and potential bias in results favouring sponsors. India’s approach to corporatisation of Science Research:
  • Since 2015 the current government Guided by ‘Dehradun Declaration’ (by CSIR lab directors), has pushed research institutions to:
  • Generate revenue by commercialising expertise
  • Reinvest profits into national technology missions
  • Self-finance research through patent marketing.
  • Operationalise the Anusandhan National Research Foundation (ANRF) as announced in Budget 2024
  • Established in 2023 under the ANRF Act of 2023, to fund research and improve R&D-academia-industry linkages.
  • Focus on basic research and prototype development, emphasising marketability.
  • Funding structure: ₹50,000 crore over 5 years, 72% expected from the private sector.

 

Way Forward:

  • Balancing Public and Private Funding: While encouraging private sector funding is important, the government of India must also increase its allocation for basic science and non-profit research.
  • Additionally, it is crucial to foster an environment of free inquiry and ensure the financial and administrative autonomy of research institutions.
  • NITI Aayog’s recent report, “Improving the Culture of Research and Development (R&D) in State Universities and Institutes,” recognizes ongoing government initiatives like Startup India, FIST, and PURSE, which are designed to enhance research capabilities in state universities and institutes.

 

International Precedents:

  • In many advanced economies,  like Germany and Japan, contributions from the private sector often surpass those from public sources. 
  • In the United States, private-sector funding has significantly outpaced government support over the past decade, 
  • Private funding accounts for 67% of total medical and health research and development (R&D) expenditures, which indicates a strong reliance on private funding within this sector.
  • In both Australia and the UK, there has been a notable trend towards the corporatisation of research in higher education.

 

Share:
Print
Apply What You've Learned.
Previous Post CSE Roadmap for India’s Carbon Market
Next Post Institutional Stigma on Dalit Business Owners
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x